miR-511-3p Modulates Genetic Programs of Tumor-Associated Macrophages

Slides:



Advertisements
Similar presentations
Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic Cells  G-One Ahn,
Advertisements

Volume 20, Issue 5, Pages (August 2017)
Volume 145, Issue 4, Pages e9 (October 2013)
Volume 21, Issue 13, Pages (December 2017)
Jeroen Witteveldt, Alasdair Ivens, Sara Macias  Cell Reports 
Volume 14, Issue 4, Pages (October 2008)
Volume 145, Issue 4, Pages e9 (October 2013)
Volume 23, Issue 3, Pages (April 2018)
Volume 2, Issue 4, Pages (April 2008)
Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
Volume 45, Issue 1, Pages (July 2016)
Volume 13, Issue 6, Pages (November 2015)
Roger B. Deal, Steven Henikoff  Developmental Cell 
Volume 21, Issue 5, Pages (October 2017)
Volume 20, Issue 12, Pages (September 2017)
Volume 136, Issue 2, Pages (February 2009)
Volume 20, Issue 3, Pages (July 2017)
Volume 3, Issue 5, Pages (November 2014)
Volume 15, Issue 9, Pages (May 2016)
Mutual Repression by Bantam miRNA and Capicua Links the EGFR/MAPK and Hippo Pathways in Growth Control  Héctor Herranz, Xin Hong, Stephen M. Cohen  Current.
Anne L. Sapiro, Patricia Deng, Rui Zhang, Jin Billy Li  Cell Reports 
Volume 21, Issue 1, Pages (October 2017)
Volume 22, Issue 13, Pages (March 2018)
Mapping Whole-Transcriptome Splicing in Mouse Hematopoietic Stem Cells
MiR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53 by Francisco Navarro, David Gutman, Eti Meire, Mario Cáceres,
Periostin Limits Tumor Response to VEGFA Inhibition
Volume 8, Issue 5, Pages (September 2014)
Volume 48, Issue 5, Pages (December 2012)
Volume 20, Issue 5, Pages (August 2017)
Cell-Type-Specific Control of Enhancer Activity by H3K9 Trimethylation
Volume 17, Issue 9, Pages (November 2016)
MiR-125b, a MicroRNA Downregulated in Psoriasis, Modulates Keratinocyte Proliferation by Targeting FGFR2  Ning Xu, Petter Brodin, Tianling Wei, Florian.
Volume 54, Issue 5, Pages (June 2014)
Volume 13, Issue 1, Pages (July 2013)
Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic Cells  G-One Ahn,
Volume 9, Issue 5, Pages (November 2017)
TALEN Gene Knockouts Reveal No Requirement for the Conserved Human Shelterin Protein Rap1 in Telomere Protection and Length Regulation  Shaheen Kabir,
Volume 15, Issue 3, Pages (April 2016)
Volume 39, Issue 6, Pages (December 2013)
Efficacy and Safety of Doubly-Regulated Vaccinia Virus in a Mouse Xenograft Model of Multiple Myeloma  Muneyoshi Futami, Kota Sato, Kanji Miyazaki, Kenshi.
Katelyn T. Byrne, Robert H. Vonderheide  Cell Reports 
ADAR Regulates RNA Editing, Transcript Stability, and Gene Expression
TNF Counterbalances the Emergence of M2 Tumor Macrophages
Volume 5, Issue 3, Pages (November 2013)
Melissa B. Uccellini, Adolfo García-Sastre  Cell Reports 
Jeroen Witteveldt, Alasdair Ivens, Sara Macias  Cell Reports 
Volume 19, Issue 9, Pages (May 2017)
Kiran Batta, Magdalena Florkowska, Valerie Kouskoff, Georges Lacaud 
Volume 5, Issue 6, Pages (December 2015)
Dan Yu, Rongdiao Liu, Geng Yang, Qiang Zhou  Cell Reports 
Volume 9, Issue 4, Pages (October 2017)
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Katelyn T. Byrne, Robert H. Vonderheide  Cell Reports 
Volume 8, Issue 3, Pages (August 2014)
MYC regulates the antitumor immune response through CD47 and PD-L1
Volume 17, Issue 3, Pages (October 2016)
The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2  Cheng-Cao Sun, Ling Zhang, Guang.
Volume 25, Issue 11, Pages e6 (December 2018)
Dissection of miRNA Pathways Using Arabidopsis Mesophyll Protoplasts
Volume 13, Issue 6, Pages (November 2015)
Cellular Heterogeneity in the Mouse Esophagus Implicates the Presence of a Nonquiescent Epithelial Stem Cell Population  Aaron D. DeWard, Julie Cramer,
Volume 25, Issue 11, Pages e3 (December 2018)
Boyan Bonev, Peter Stanley, Nancy Papalopulu  Cell Reports 
Volume 28, Issue 5, Pages (May 2008)
Volume 33, Issue 1, Pages (July 2010)
Volume 10, Issue 7, Pages (February 2015)
The Genetic Landscape of Hematopoietic Stem Cell Frequency in Mice
A Splicing-Independent Function of SF2/ASF in MicroRNA Processing
A Double-Switch Vector System Positively Regulates Transgene Expression by Endogenous microRNA Expression (miR-ON Vector)  Mario Amendola, Alice Giustacchini,
Endogenous Control of Immunity against Infection: Tenascin-C Regulates TLR4- Mediated Inflammation via MicroRNA-155  Anna M. Piccinini, Kim S. Midwood 
Presentation transcript:

miR-511-3p Modulates Genetic Programs of Tumor-Associated Macrophages Mario Leonardo Squadrito, Ferdinando Pucci, Laura Magri, Davide Moi, Gregor D. Gilfillan, Anna Ranghetti, Andrea Casazza, Massimiliano Mazzone, Robert Lyle, Luigi Naldini, Michele De Palma  Cell Reports  Volume 1, Issue 2, Pages 141-154 (February 2012) DOI: 10.1016/j.celrep.2011.12.005 Copyright © 2012 The Authors Terms and Conditions

Cell Reports 2012 1, 141-154DOI: (10.1016/j.celrep.2011.12.005) Copyright © 2012 The Authors Terms and Conditions

Figure 1 miR-511-3p Is the Active Strand of Mouse Pre-miR-511 and Is Coregulated with the Mrc1 Gene (A) Genomic region comprising the mouse miR-511 locus and the surrounding Mrc1 gene on mouse chromosome 2, as retrieved by the UCSC (NCBI37/mm9) genome browser. (B) Stem-loop structure of the mouse pre-miR-511. miR-511-5p and -3p sequences are shown in blue and red, respectively. (C) Schematic of the proviral LV used to measure miR-511 activity (miRT-511 LV). The miRT sequences are cloned downstream to the GFP expression cassette, which is regulated by a bidirectional PGK promoter. (D) Schematic of the proviral LV used to overexpress miR-511 (SFFV.miR-511 LV). The sequence of the primary miR-511 is cloned within the EF1α intron, downstream to a SFFV promoter. (E) miR-511-5p and -3p activity in 293T cells overexpressing miR-511. The cells were transduced with the miRT-511-5p, -3p, or no-miRT reporter LVs, and superinfected with the SFFV.miR-511 overexpressing LV. Dot plots show GFP and ΔLNGFR expression from the indicated reporter LVs. The histogram on the right shows quantification of GFP repression (mean values ±SEM versus no-miRT control; n = 2 independent experiments). Statistical analysis of fold-repression values was performed by unpaired Student's t test. (F) Expression of the Mrc1 gene in BMDMs (MΦ; either untreated or stimulated as indicated), P388D1 and RAW264.7 cells. Data show mean ΔCt values ±SEM versus β2 m; n = 2–3 independent experiments. Statistical analysis of ΔCt values was performed by unpaired Student's t test. (G) Endogenous miR-511-5p and -3p activity in BMDMs (MΦ; either untreated or stimulated as indicated), P388D1 and RAW264.7 cells. The histograms show GFP repression (mean values ±SEM versus no-miRT control; n = 2–8 independent experiments). Statistical analysis of fold-repression values was performed by unpaired Student's t test. (H) MRC1 protein expression in BMDMs either untreated or stimulated as indicated. The black open line is the fluorescence minus one (FMO) control for the anti-MRC1 antibody. Data are representative of two independent experiments. (I) Endogenous miR-511-3p activity in IL-4-stimulated BMDMs. Top panels show MRC1 protein in BMDMs either untreated or stimulated by IL-4; cell nuclei were stained by DAPI. Bottom panels show GFP in IL-4-stimulated BMDMs either transduced with the no-miRT or miRT-511-3p reporter LV; the cell's actin cytoskeleton was stained by phalloidin. (J) Correlation between GFP repression and MRC1 protein in BMDMs either untreated or stimulated with IL-4; the cells were previously transduced with the miRT-511-5p, -3p, or no-miRT reporter LVs. GFP expression was measured after fractionating the cells according to different MRC1 protein levels (Neg, negative; Low; Int, intermediate; High; see H). Statistical analysis was performed by Spearman's rank correlation test. Cell Reports 2012 1, 141-154DOI: (10.1016/j.celrep.2011.12.005) Copyright © 2012 The Authors Terms and Conditions

Figure 2 Preferential Expression and Activity of miR-511-3p in MRC1+ TAMs (A) miR-511-3p activity in LLC grown in C57BL/6 mice. Left view shows flow cytometry analysis of GFP and ΔLNGFR in MRC1+ and CD11c+ TAMs. Right view illustrates GFP repression in the indicated cell types (versus no-miRT control). Each dot in the scatterplot corresponds to one mouse (n = 4–6/group). Statistical analysis of fold-repression values was performed by unpaired Student's t test. (B) miR-511-3p activity in N202 mammary carcinomas grown in FVB/n mice (n = 5–6 mice/group). Statistical analysis of fold-repression values was performed by unpaired Student's t test. (C) GFP (green), MRC1 (red), and CD11c immunostaining or nuclear staining by TO-PRO-3 (blue) of N202 mammary tumors grown in FVB/n mice. Arrows indicate GFP+MRC1+ TAMs. Scale bars, 150 μm (left panels) and 30 μm (RIGHT panels). Results are representative of four tumors/group. (D) qPCR of selected miRNAs in MRC1+ and CD11c+ TAMs isolated from MMTV-PyMT mammary tumors. The data show relative abundance of each miRNA (mean values ±SEM versus Let7a; n = 3 biological samples). Statistical analysis of ΔCt values was performed by unpaired Student's t test. (E) qPCR of selected mRNAs in MRC1+ and CD11c+ TAMs isolated from MMTV-PyMT mammary tumors. The data show fold change (= 2ΔCt; mean values ±SEM; n = 3 biological samples) versus CD11c+ TAMs (reference population). Normalization was performed by interpolating Gapdh and β2 m. Statistical analysis of ΔCt values was performed by unpaired Student's t test. Cell Reports 2012 1, 141-154DOI: (10.1016/j.celrep.2011.12.005) Copyright © 2012 The Authors Terms and Conditions

Figure 3 Preferential Expression and Activity of miR-511-3p in MRC1+ Tissue-Resident Macrophages (A–D) Flow cytometry analysis of F4/80+ tissue-resident macrophages (further separated based on MRC1 and CD11c expression), Gr1+F4/80− granulocytes, and CD11c+F4/80− DCs, in the indicated tissues/organs of FVB/n mice. Flow cytometry dot plots on the left show the gating strategy. The scatterplot on the right shows GFP repression (versus no-miRT control) in the individual cell types. Each dot in the scatterplot corresponds to one mouse. Statistical analysis of fold-repression values was performed by unpaired Student's t test. (E) qPCR of selected miRNAs in MRC1+ and CD11c+ adipose tissue macrophages isolated from FVB/n mice. The data show relative abundance of each miRNA (mean values ±SEM versus Let7a; n = 3 biological samples). Statistical analysis of the data was performed on ΔCt values by unpaired Student's t test. (F) qPCR of selected mRNAs in the adipose tissue macrophages. The data show fold change (= 2ΔCt; mean values ±SEM; n = 3 biological samples) versus CD11c+ macrophages (reference population). Normalization was performed by β2 m. Note that Tie2 was undetectable in CD11c+ macrophages. Statistical analysis of ΔCt values was performed by unpaired Student's t test. Cell Reports 2012 1, 141-154DOI: (10.1016/j.celrep.2011.12.005) Copyright © 2012 The Authors Terms and Conditions

Figure 4 ROCK2 Is a Direct Target of Mouse miR-511-3p (A) GFP repression in RAW264.7 cells transduced with the miRT-511-5p or -3p LVs and superinfected with the miR-511 or -511-mut overexpressing LVs (mean values ±SEM versus untransduced [UT] cells; n = 3 independent experiments). Statistical analysis of fold-repression values was performed by two-way ANOVA with Bonferroni posttest. (B) Firefly luciferase activity in 293T cells untransduced or transduced with either miR-511 or -511-mut LV. The 3′ UTRs of mouse podoplanin (Pdpn), semaphorin-3A (Sema3a), Rock2 (all miR-511-3p target genes), and CD163 were tested, together with a UTR-less plasmid (miRGLO). The Rock2 UTR was split into two fragments (Rock2(1) and Rock2(2)). The box-and-whisker graph shows luciferase activity (median ± minimum/maximum values versus miRGLO; n = 6–9 technical replicates from 3 independent experiments). Statistical analysis was performed by two-way ANOVA with Bonferroni posttest. (C) GFP repression in P388D1 cells transduced with GFP reporter LVs containing either wild-type or mutant UTR sequences from the Rock2 gene. Cells were superinfected with either miR-511 or -511-mut overexpressing LV. Data show fold change of GFP repression (mean ± SEM; n = 3 independent experiments). Statistical analysis was performed by two-way ANOVA with Bonferroni posttest. (D) qPCR of Rock2 expression in RAW264.7 cells overexpressing either miR-511or -511-mut. The data show fold change (= 2ΔCt; mean values ±SEM; n = 3 biological samples) versus untransduced cells (reference population). Normalization was performed by β2 m. Statistical analysis was performed on actual ΔCt values by unpaired Student's t test. (E) Western blot analysis of ROCK2 in RAW264.7 cells either overexpressing miR-511 or -511-mut. The left histograms show quantification of ROCK2/GAPDH signal (normalized to miR-511-mut; seven technical replicates from three independent experiments). Statistical analysis was performed by paired Student's t test. A representative blot is shown on the right. (F) qPCR of Rock2 expression in P388D1 cells overexpressing either miR-511or -511-mut. The data show fold change (= 2ΔCt; mean values ±SEM; n = 3 biological samples) versus untransduced cells (reference population). Normalization was performed by Hprt. Statistical analysis of ΔCt values was performed by unpaired Student's t test. (G and H) Western blot analysis of ROCK2 in P388D1 cells (G) or BMDMs (H) overexpressing either miR-511 or -511-mut. Analysis as in (E) (P388D1: nine technical replicates, three independent experiments; BMDMs: four technical replicates, two independent experiments). Cell Reports 2012 1, 141-154DOI: (10.1016/j.celrep.2011.12.005) Copyright © 2012 The Authors Terms and Conditions

Figure 5 ROCK2 Is a Direct Target of Human miR-511-3p (A) miR-511-3p and -5p activity in U937 cells overexpressing either miR-511 or -511-mut. The histogram shows GFP repression (mean values ±SEM versus untransduced cells; n = 3 independent experiments). Statistical analysis of fold-repression values was performed by two-way ANOVA with Bonferroni posttest. (B) Western blot analysis of ROCK2 in U937 cells overexpressing either miR-511 or -511-mut. The left histograms show quantification of ROCK2/GAPDH signal (normalized to miR-511-mut; nine technical replicates from three independent experiments). Statistical analysis was performed by paired Student's t test. A representative blot is shown on the right. (C) GFP repression in U937 cells transduced with GFP reporter LVs containing either wild-type or mutant UTR sequences from the ROCK2 gene. Cells were superinfected with either miR-511 or -511-mut overexpressing LV. Data show fold change of GFP repression (mean ± SEM; n = 3 independent experiments). Statistical analysis was performed by two-way ANOVA with Bonferroni posttest. Cell Reports 2012 1, 141-154DOI: (10.1016/j.celrep.2011.12.005) Copyright © 2012 The Authors Terms and Conditions

Figure 6 miR-511-3p Overexpression in TAMs Inhibits Tumor Growth and Alters Blood Vessel Morphology (A) LLC growth in mice overexpressing either miR-511or -511-mut in hematopoietic cells. Data show tumor volumes (mean values ±SEM; n = 11 mice/group). Statistical analysis was performed by unpaired Student's t test. One representative experiment of two performed is shown. (B) Whole-mount visualization of blood vessels by Microfill perfusion. LLCs (n = 5/group) were grown in mice overexpressing either miR-511 or -511-mut in hematopoietic cells. (C) Representative 200-μm-thick tumor sections (of eight sections/tumor and n = 5 tumors/group). The inset in the bottom panel shows blood vessels with glomerular morphology. Scale bar, 200 μm. (D) Morphometric analysis of blood vessels in LLCs (n = 5/group) grown in mice overexpressing either miR-511or -511-mut in hematopoietic cells. Data were obtained by analyzing eight sections/tumor (four from the tumor periphery and four from the central tumor mass) and n = 5 tumors/group. Data are expressed as arbitrary units. Statistical analysis was performed by unpaired Student's t test. Cell Reports 2012 1, 141-154DOI: (10.1016/j.celrep.2011.12.005) Copyright © 2012 The Authors Terms and Conditions

Figure 7 miR-511-3p Overexpression in TAMs Tunes Down Their Protumoral Gene Signature (A) qPCR of selected miRNAs in F4/80+OFP+ TAMs isolated from LLCs grown in mice overexpressing either miR-511 or -511-mut in hematopoietic cells. The data show the relative abundance of each miRNA (mean values ±SEM versus Let7a; n = 4 biological samples). Statistical analysis of ΔCt values was performed by unpaired Student's t test. (B) Cumulative distribution of fold changes in the whole transcriptome (13,747 genes; transcripts with less than 10 reads, and miR-511-3p predicted targets were excluded from the analysis) of TAMs overexpressing miR-511 (versus -511-mut; red line). The green line shows the cumulative distribution of fold changes in transcripts that are miR-511-3p predicted targets (145 genes). Note the global repression of miR-511-3p target genes. Statistical analysis was performed by one-sided Kolmogorov-Smirnov test. (C–E) Cumulative distribution of fold changes in the whole transcriptome (13,747 genes; transcripts with less than 10 reads, and miR-511-3p predicted targets were excluded) of TAMs overexpressing miR-511 (versus -511-mut; red line). The green and blue lines show the cumulative distribution of fold changes in transcripts that contain M8-A1 8-mer and M8 7-mer target sites, respectively, for miR-511-3p (C), -5p (D), or -3p-mut (E). Statistical analysis was performed by one-sided Kolmogorov-Smirnov test. (F) qPCR of Ltbp1 expression in P388D1 cells overexpressing either miR-511or -511-mut. The data show fold change (= 2ΔCt; mean values ±SEM; n = 3 biological samples) versus miR-511-3p-mut (reference population). Normalization was performed by Hprt. Statistical analysis of ΔCt values was performed by unpaired Student's t test. (G) Western blot analysis of LTBP1 in BMDMs either overexpressing mouse miR-511 or -511-mut. The left histograms show quantification of LTBP1/calnexin (CLNX) signal (normalized to miR-511-mut; four technical replicates from two independent experiments). Statistical analysis was performed by paired Student's t test. A representative blot is shown on the right. (H) Cumulative distribution of fold changes in the whole transcriptome (16,355 genes) of TAMs overexpressing miR-511 (versus -511-mut; red line). The green line shows the cumulative distribution of fold changes in transcripts that are upregulated in MRC1+ TAMs (versus CD11c+ TAMs; 1,365 genes); The blue line shows the cumulative distribution of fold changes in the transcripts that are upregulated in CD11c+ TAMs (versus MRC1+ TAMs; 1,596 genes). Statistical analysis was performed by one-sided Kolmogorov-Smirnov test. (I) Scatterplot distribution of fold changes in gene expression of MRC1+ and CD11c+ TAMs overexpressing miR-511 (versus -511-mut). The x axis shows the upregulation of transcripts in MRC1+ versus CD11c+ TAMs (left; MRC1+ TAM gene signature) or CD11c+ versus MRC1+ TAMs; (right; CD11c+ TAM gene signature). The y axis shows changes in gene expression by miR-511 overexpression (versus -511-mut). Transcripts with less than ten reads were excluded from the analysis. Statistical analysis of the data is presented in (H). (J) qPCR of Rock2 expression in MRC1+ and CD11c+ TAMs isolated from LLCs. The data show fold change (= 2ΔCt; mean values ±SEM; n = 2 biological samples) versus CD11c+ TAMs (reference population). Normalization was performed by β2 m. Statistical analysis of ΔCt values was performed by unpaired Student's t test. (K) qPCR of Rock2 expression in BMDMs either untreated or stimulated by IL-4; the cells were transduced with either miR-511 or -511-mut overexpressing LV. Data show fold change in Rock2 repression (mean ± SEM; n = 3 independent experiments) versus untreated cells. Note that miR-511 overexpression abrogates IL-4-induced Rock2 upregulation in the cells. Statistical analysis was performed by two-way ANOVA with Bonferroni posttest. Cell Reports 2012 1, 141-154DOI: (10.1016/j.celrep.2011.12.005) Copyright © 2012 The Authors Terms and Conditions

Figure S1 Immunophenotyping of P388D1 and RAW264.7 Monocytic Cells, Related to Figure 1 P388D1 cells were stained with the indicated antibodies to analyze the expression of myeloid (CD11b, CD11c), monocyte/macrophage (F4/80), B cell (CD19) and T cell (CD3) markers (top row). Unstained cells (fluorescence-minus one, FMO) are shown in the bottom row. RAW264.7 cells were stained with the indicated antibodies to analyze the expression of myeloid (CD11b, CD11c), monocyte/macrophage (F4/80) and T cell (CD3) markers (top row). Unstained cells (FMO) are shown in the bottom row. Note that both P388D1 and RAW264.7 cells express the monocyte/macrophage-specific marker, F4/80. Cell Reports 2012 1, 141-154DOI: (10.1016/j.celrep.2011.12.005) Copyright © 2012 The Authors Terms and Conditions

Figure S2 Identification of Tumor-Infiltrating Hematopoietic Cells in Lewis Lung Carcinoma (LLC) and N202 Mammary Carcinoma, Related to Figure 2 (A) LLCs grown for 4 weeks in C57BL/6 mice. Left panel: Flow cytometry analysis of the following circulating leukocyte subsets: CD115+Gr1– resident monocytes (1); CD115+Gr1+ inflammatory monocytes (also termed myeloid-derived suppressor cells in tumor-bearing mice) (2); and CD115–GR1+ granulocytes (3). Middle and right panels: Flow cytometry analysis of tumor-derived leukocytes; tumors were harvested and made into single-cell suspensions. Middle panels: 7-AAD–CD11b+F4/80+MRC1+CD11clow TAMs (1); and 7-AAD–CD11b+F4/80+CD11c+MRC1low TAMs (2). Right panels: 7-AAD–CD45+CD11b+F4/80–Gr1+ granulocytes/immature myeloid cells (iMCs) (1). (B) N202 mammary carcinomas grown for 4 weeks in FVB/n mice. Tumors were harvested and made into single cell suspensions, and the following cell types analyzed: 7-AAD–Gr1+F4/80– granulocytes/iMCs (1); 7-AAD–F4/80+Gr1–MRC1+CD11clow TAMs (2); and 7-AAD–F4/80+Gr1–CD11c+MRC1low TAMs (3). Cell Reports 2012 1, 141-154DOI: (10.1016/j.celrep.2011.12.005) Copyright © 2012 The Authors Terms and Conditions

Figure S3 Stem-Loop Structures of the Mouse Pre-miR-511 and Pre-miR-511-mut, and Annotated Sequences of the Wild-Type and Mutated Mouse Rock2 3′ UTR, Related to Figure 4 (A) Stem-loop structures of the mouse pre-miR-511 and pre-miR-511-mut. miR-511-5p and −3p sequences are shown in blue and red, respectively; Mutated nucleotides are shown in green. Note that both pre-miR-511 and pre-miR-511-mut generate a wild-type miR-511-5p sequence upon processing of the pre-miRNA. (B) Core sequence of the mouse Rock2 3′-UTR. Wild-type sequence: The genomic sequence of the Rock2 3′-UTR encompassing the miR-511-3p target sites is illustrated. Four target sites (8-mer-A1; 7-mer-M8; 7-mer-M8; 6-mer) are indicated by red letters, and the binding of the miRNA illustrated for each site. Interactions were retrieved by RNA-Hybrid. Mutated sequence: Each of the four miR-511-3p target sites was mutated by substituting 3 nucleotides in each site. Mutated nucleotides are underlined and shown in gray boxes. Cell Reports 2012 1, 141-154DOI: (10.1016/j.celrep.2011.12.005) Copyright © 2012 The Authors Terms and Conditions

Figure S4 Stem-Loop Structures of the Human Pre-miR-511 and Pre-miR-511-mut, and Annotated Sequences of the Wild-Type and Mutated Human ROCK2 3′ UTR, Related to Figure 5 (A) Conservation of miR-511-5p and miR-511-3p among species. The yellow shading indicates 100% identity. (B) Stem-loop structures of the human pre-miR-511 and pre-miR-511-mut. miR-511-5p and −3p sequences are shown in blue and red, respectively; Mutated nucleotides are shown in green. Note that both pre-miR-511 and pre-miR-511-mut generate a wild-type miR-511-5p sequence upon processing of the pre-miRNA. (C) Core sequence of the human ROCK2 3′-UTR. Wild-type sequence: The genomic sequence of the ROCK2 3′-UTR encompassing the miR-511-3p target sites is illustrated. Three target sites (8-mer-A1; 7-mer-M8; 7-mer-M8) are indicated by red letters, and the binding of the miRNA illustrated for each site. Interactions were retrieved by RNA-Hybrid. Mutated sequence: Each of the three miR-511-3p target sites was mutated by substituting 3 nucleotides in each site. Mutated nucleotides are underlined and shown in gray boxes. Cell Reports 2012 1, 141-154DOI: (10.1016/j.celrep.2011.12.005) Copyright © 2012 The Authors Terms and Conditions

Figure S5 Hematopoietic Chimerism and Identification of Tumor-Infiltrating Hematopoietic Cells in LLCs of miR-511-Overexpressing Mice, Related to Figure 6 (A) Proportions of CD45.1+ and CD45.1+OFP+ leukocytes in the blood of mice either overexpressing miR-511-3p (SFFV.miR-511) or miR-511-3p-mut (SFFV.miR-511-mut) in hematopoietic cells. Blood leukocytes were analyzed at the end of the experiment (8 weeks post-HS/PC transplant). Data show the percentage of marker-positive cells (mean values ± SEM; n = 4 mice/group). (B) Proportions of B cells (CD19+), NK cells (NK1.1+), CD8+ T cells, total TAMs (F4/80+), and granulocytes (GR1+) among the total LLC-infiltrating CD45+ hematopoietic cells. Tumors were analyzed at the end of the experiment (8 weeks post-HS/PC transplant; 4 weeks post-tumor injection). Data show the percentage of marker-positive cells (mean values ± SEM; n = 4 mice/group). (C) Proportion of MRC1+ and CD11c+ TAMs among the total F4/80+ TAMs in LLCs grown in mice either overexpressing miR-511 or −511-mut in hematopoietic cells. Tumors were analyzed at the end of the experiment (8 weeks post-HS/PC transplant; 4 weeks post-tumor injection). Data show the percentage of marker-positive cells (mean values ± SEM; n = 4 mice/group). Cell Reports 2012 1, 141-154DOI: (10.1016/j.celrep.2011.12.005) Copyright © 2012 The Authors Terms and Conditions